Table 1.

Comparison of the demographic and underlying diagnosis between the listed and non-listed groups.

	Listed (N=10)		Non-listed (N=15)		p value
	Median	(25%-75%)	Median	(25%-75%)
Age at entry (years)	11.4	(5.6-13.9)	3.8	(2.1-6.2)	0.01
Time from diagnosis to entry (months)	9.5	(1.8-133.7)	36	(24.8-46.2)	0.37
Height (Z-score)	−0.8	(−1.5- −0.0)	0	(−1- 0.9)	0.25
Weight (Z-score)	0	(−1.0- 0.5)	0	(−0.9- 2.5)	0.86
* BSA (m2)	1.2	(0.8-1.6)	0.6	(0.5-0.8)	0.03
Gender (Male/Female)	5/6		10/5		0.37
Diagnosis:					0.09
†CHD (%)	2	(20)	0	(0)
‡DCM (%)	5	(50)	13	(87)
Myocarditis (%)	3	(30)	2	(13)
NYHA classification					0.0002
II (%)	2	(20)	14	(93)
III (%)	3	(30)	1	(7)
IV (%)	5	(50)	0	(0)
£ N° oral medications	3.5	(2-4)	2	(2-3)	0.67
* N° IV Inotropes	1	(0-1)	0	0	0.0015

Numbers in parentheses are the ranges expressed as 25th and 75th percentiles, except for diagnosis where the numbers in parentheses are percentages.

^*BSA: Body surface area.

^†CHD: Congenital heart disease. Atrioventricular canal with Shone’s complex (1 patient) and multiple ventricular septal defects status post pulmonary artery banding (1 patient).

^‡DCM: Dilated cardiomyopathy. Idiopathic (11 non-transplanted patients, 4 listed patients), familial (2 non-listed patients), congenital (1 listed patient).

^£N° oral medications: Number of oral medications (Diuretics, angiotensin-converting-enzyme inhibitors, carvedilol and digoxin).

^§N° IV Inotropes: Number of intravenous intropic agents (Milrinone and dopamine).